CRBP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.00%

Insider Buying (Last 12 Months): $40,378,055.68

Insider Selling (Last 12 Months): $2,530,798.76

Corbus Pharmaceuticals Insider Trading History Chart

Corbus Pharmaceuticals Share Price & Price History

^$16.92

▲ +0.96 (6.02%)

As of 11/1/2024 01:00 AM ET

Days: 30 | 90 | 365

Tim Sykes’ Urgent Trade Alert: “Make this move now”

From Timothy Sykes | Ad

Click here to see the surprising reason why

Corbus Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/20/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	350,000	$20.01	$7,003,500.00	2,375,000
6/18/2024	Sean F Moran	CFO	Sell	1,958	$42.12	$82,470.96	48,605
6/17/2024	Yuval Cohen	CEO	Sell	11,103	$46.02	$510,960.06	84,400
6/14/2024	Sean F Moran	CFO	Sell	9,355	$49.87	$466,533.85	48,605
6/14/2024	Yuval Cohen	CEO	Sell	29,317	$50.17	$1,470,833.89	84,400
3/7/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	250,000	$40.05	$10,012,500.00	1,725,000
2/2/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	750,000	$19.00	$14,250,000.00	1,475,000
1/26/2024	Cormorant Asset Management, Lp	Major Shareholder	Buy	282,632	$32.24	$9,112,055.68	725,000
8/10/2022	Craig Stuart Millian	COO	Buy	5,000	$0.25	$1,250.00	27,000
8/10/2022	Sean F Moran	CFO	Buy	20,000	$0.26	$5,200.00	199,272
8/10/2022	Yuval Cohen	CEO	Buy	3,800	$0.26	$988.00	98,230
5/16/2022	Sean F Moran	CFO	Buy	12,000	$0.30	$3,600.00	179,272
5/16/2022	Yuval Cohen	CEO	Buy	10,500	$0.25	$2,625.00	94,430
3/10/2022	Craig Stuart Millian	COO	Buy	10,000	$0.37	$3,700.00
3/10/2022	Sean F Moran	CFO	Buy	15,000	$0.37	$5,550.00
3/9/2022	Yuval Cohen	CEO	Buy	8,600	$0.37	$3,182.00

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Corbus Pharmaceuticals (NASDAQ:CRBP)

64.64% of Corbus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Corbus Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/25/2024	abrdn plc	26,894	$0.56M	0.0%	+422.9%	0.252%
10/23/2024	Assenagon Asset Management S.A.	221,184	$4.56M	0.0%	-7.4%	2.070%
10/3/2024	SG Americas Securities LLC	7,331	$0.15M	0.0%	N/A	0.069%
8/19/2024	Point72 Asset Management L.P.	216,515	$9.80M	0.0%	-69.1%	2.026%
8/15/2024	The Manufacturers Life Insurance Company	21,131	$0.96M	0.0%	+100.7%	0.198%
8/15/2024	Millennium Management LLC	241,649	$10.94M	0.0%	-25.6%	2.261%
8/15/2024	Darwin Global Management Ltd.	325,140	$14.27M	1.7%	N/A	3.042%
8/14/2024	Integral Health Asset Management LLC	100,000	$4.53M	0.4%	N/A	0.936%
8/14/2024	HighVista Strategies LLC	38,793	$1.76M	0.6%	N/A	0.363%
8/13/2024	Ensign Peak Advisors Inc	45,364	$2.05M	0.0%	-32.8%	0.424%
8/7/2024	ClariVest Asset Management LLC	16,021	$0.73M	0.1%	N/A	0.150%
8/6/2024	Acadian Asset Management LLC	15,854	$0.72M	0.0%	N/A	0.148%
8/5/2024	Victory Capital Management Inc.	19,060	$0.86M	0.0%	N/A	0.178%
8/3/2024	TD Asset Management Inc	40,800	$1.85M	0.0%	+92.5%	0.382%
8/1/2024	Rhumbline Advisers	14,103	$0.64M	0.0%	N/A	0.132%
7/26/2024	Bank of New York Mellon Corp	30,236	$1.37M	0.0%	N/A	0.283%
7/18/2024	Assenagon Asset Management S.A.	238,759	$10.80M	0.0%	-8.0%	2.233%
5/17/2024	Ikarian Capital LLC	559,271	$21.95M	2.4%	+185.5%	5.232%
5/16/2024	Janus Henderson Group PLC	339,074	$13.36M	0.0%	N/A	3.172%
5/15/2024	Price T Rowe Associates Inc. MD	192,495	$7.55M	0.0%	N/A	1.801%
5/15/2024	Altitude Crest Partners Inc.	103,703	$4.07M	1.7%	N/A	0.970%
5/10/2024	Vanguard Group Inc.	437,264	$17.16M	0.0%	+143.7%	4.162%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	24,880	$0.98M	0.0%	N/A	0.237%
4/24/2024	Assenagon Asset Management S.A.	259,456	$10.18M	0.0%	N/A	2.469%
5/15/2023	Sio Capital Management LLC	150,000	$1.09M	0.5%	N/A	3.559%
5/10/2023	Tekla Capital Management LLC	5,143	$37K	0.0%	-96.7%	0.122%
5/1/2023	Virtu Financial LLC	10,077	$73K	0.0%	N/A	0.239%
1/25/2023	Pinnacle Associates Ltd.	731,350	$84K	0.0%	-11.6%	0.584%
11/15/2022	ETF Managers Group LLC	4,710,319	$0.78M	0.0%	-33.3%	3.760%
11/10/2022	ExodusPoint Capital Management LP	362,544	$60K	0.0%	N/A	0.289%
11/1/2022	Pinnacle Associates Ltd.	827,240	$0.14M	0.0%	-9.1%	0.660%
8/12/2022	Ikarian Capital LLC	862,527	$0.22M	0.0%	-13.5%	0.689%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	4,029,171	$1.02M	0.0%	+7.3%	3.217%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	3,754,954	$2M	0.0%	-7.7%	2.998%
5/11/2022	GSA Capital Partners LLP	517,806	$0.28M	0.0%	N/A	0.413%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	3,754,954	$2M	0.0%	-7.7%	2.998%
5/5/2022	Pinnacle Associates Ltd.	914,887	$0.49M	0.0%	-3.4%	0.731%
4/28/2022	Davy Global Fund Management Ltd	435,285	$0.23M	0.0%	+36.6%	0.348%
2/14/2022	ETF Managers Group LLC	14,138,998	$8.53M	0.2%	+0.3%	11.290%
2/10/2022	Acadian Asset Management LLC	184,026	$0.11M	0.0%	N/A	0.147%
2/8/2022	Mirae Asset Global Investments Co. Ltd.	4,070,006	$2.51M	0.0%	+1.7%	3.250%
2/3/2022	Cambridge Investment Research Advisors Inc.	115,919	$71K	0.0%	+27.5%	0.093%
2/2/2022	Davy Global Fund Management Ltd	318,668	$0.20M	0.0%	+10.0%	0.254%
1/18/2022	Aries Wealth Management	107,800	$66K	0.0%	+360.7%	0.086%
1/14/2022	Spire Wealth Management	45,000	$28K	0.0%	N/A	0.036%
11/15/2021	Penserra Capital Management LLC	434,874	$0.44M	0.0%	+19.2%	0.347%
11/12/2021	Geode Capital Management LLC	1,386,108	$1.41M	0.0%	+2.1%	1.107%
11/12/2021	Vident Investment Advisory LLC	147,113	$0.15M	0.0%	N/A	0.117%
11/9/2021	BlackRock Inc.	2,566,443	$2.62M	0.0%	+8.7%	2.049%
10/27/2021	Davy Global Fund Management Ltd	289,627	$0.30M	0.0%	-90.0%	0.231%
10/19/2021	Pinnacle Associates Ltd.	966,014	$0.99M	0.0%	-3.2%	0.771%
9/17/2021	Virtu Financial LLC	85,031	$0.16M	0.0%	-44.3%	0.068%
9/3/2021	Parametric Portfolio Associates LLC	61,837	$0.11M	0.0%	+126.8%	0.049%
8/26/2021	Y Intercept Hong Kong Ltd	20,467	$37K	0.0%	N/A	0.016%
8/17/2021	Walleye Capital LLC	168,824	$0.31M	0.0%	N/A	0.135%
8/17/2021	Walleye Trading LLC	56,659	$0.10M	0.0%	N/A	0.045%
8/17/2021	Millennium Management LLC	1,242,977	$2.28M	0.0%	N/A	0.994%
8/17/2021	Price T Rowe Associates Inc. MD	28,410	$52K	0.0%	+148.3%	0.023%
8/17/2021	Boothbay Fund Management LLC	128,350	$0.24M	0.0%	+15.7%	0.103%
8/16/2021	LMR Partners LLP	29,228	$53K	0.0%	N/A	0.023%
8/16/2021	Cubist Systematic Strategies LLC	36,903	$68K	0.0%	-62.9%	0.030%
8/16/2021	Morgan Stanley	2,592,114	$4.74M	0.0%	-34.6%	2.073%
8/16/2021	Credit Suisse AG	59,269	$0.11M	0.0%	+307.0%	0.047%
8/16/2021	State Street Corp	352,709	$0.65M	0.0%	-77.2%	0.282%
8/16/2021	Tibra Equities Europe Ltd	145,500	$0.27M	0.1%	N/A	0.116%
8/16/2021	Goldman Sachs Group Inc.	61,514	$0.11M	0.0%	-71.4%	0.049%
8/13/2021	Northern Trust Corp	213,327	$0.39M	0.0%	-73.2%	0.171%
8/13/2021	Jump Financial LLC	23,466	$43K	0.0%	N/A	0.019%
8/13/2021	Geode Capital Management LLC	1,357,449	$2.48M	0.0%	-15.6%	1.086%
8/13/2021	Vanguard Group Inc.	5,462,050	$10M	0.0%	+43.6%	4.368%
8/12/2021	Penserra Capital Management LLC	364,964	$0.67M	0.0%	+204.2%	0.292%
8/12/2021	Dimensional Fund Advisors LP	65,794	$0.12M	0.0%	N/A	0.053%
8/12/2021	JPMorgan Chase & Co.	187,252	$0.34M	0.0%	-53.3%	0.150%
8/12/2021	Bank of Montreal Can	17,925	$33K	0.0%	+763.0%	0.014%
8/12/2021	Ergoteles LLC	317,400	$0.58M	0.0%	N/A	0.254%
8/11/2021	Bank of New York Mellon Corp	197,232	$0.36M	0.0%	-26.2%	0.158%
8/11/2021	BlackRock Inc.	2,362,071	$4.32M	0.0%	-58.4%	1.889%
8/11/2021	Deutsche Bank AG	54,008	$98K	0.0%	-20.2%	0.043%
8/11/2021	Susquehanna Fundamental Investments LLC	53,033	$97K	0.0%	-74.3%	0.042%
8/10/2021	JTC Employer Solutions Trusteee Ltd	33,185	$61K	0.0%	N/A	0.027%
8/5/2021	Platform Technology Partners	60,000	$0.11M	0.0%	N/A	0.048%
8/4/2021	Graypoint LLC	13,420	$25K	0.0%	N/A	0.011%
8/4/2021	Creative Planning	238,024	$0.44M	0.0%	-54.7%	0.190%
8/2/2021	Pinnacle Associates Ltd.	998,229	$1.83M	0.0%	+1.5%	0.798%
7/31/2021	Davy Global Fund Management Ltd	2,884,251	$5.28M	0.8%	+33.4%	2.307%
5/18/2021	D. E. Shaw & Co. Inc.	541,302	$1.07M	0.0%	-73.9%	0.433%
5/18/2021	Morgan Stanley	3,961,808	$7.80M	0.0%	+427.5%	3.169%
5/18/2021	Cubist Systematic Strategies LLC	99,565	$0.20M	0.0%	N/A	0.080%
5/17/2021	Royal Bank of Canada	83,657	$0.16M	0.0%	+80.2%	0.067%
5/17/2021	HRT Financial LP	118,862	$0.23M	0.0%	-86.5%	0.095%
5/17/2021	Nuveen Asset Management LLC	253,115	$2.34M	0.0%	+3.3%	0.202%
5/17/2021	Ikarian Capital LLC	964,100	$1.90M	0.1%	+593.1%	0.771%
5/17/2021	Goldman Sachs Group Inc.	214,971	$0.42M	0.0%	+253.5%	0.172%
5/14/2021	Stifel Financial Corp	12,619	$25K	0.0%	-44.5%	0.010%
5/13/2021	Barclays PLC	64,217	$0.13M	0.0%	N/A	0.051%
5/13/2021	NewEdge Wealth LLC	18,800	$37K	0.0%	N/A	0.015%
5/13/2021	Penserra Capital Management LLC	119,988	$0.24M	0.0%	+14.9%	0.096%
5/13/2021	Bank of New York Mellon Corp	267,113	$0.53M	0.0%	+18.0%	0.214%
5/13/2021	Citigroup Inc.	16,683	$33K	0.0%	-47.6%	0.013%
5/13/2021	Mirae Asset Global Investments Co. Ltd.	3,396,393	$6.69M	0.0%	+65.7%	2.716%

Data available starting January 2016

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.

Today's Range

Now: $16.92

$16.12

$16.97

50 Day Range

MA: $32.28

$15.96

$61.18

52 Week Range

Now: $16.92

$3.03

$61.90

Volume

248,082 shs

Average Volume

578,707 shs

Market Capitalization

$203.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.53

Who are the company insiders with the largest holdings of Corbus Pharmaceuticals?: Corbus Pharmaceuticals' top insider shareholders include:
Cormorant Asset Management, Lp (Major Shareholder)
Yuval Cohen (CEO)
Sean F Moran (CFO)
Learn More about top insider investors at Corbus Pharmaceuticals.
Who are the major institutional investors of Corbus Pharmaceuticals?: Corbus Pharmaceuticals' top institutional investors include:
Assenagon Asset Management S.A. — 2.07%
abrdn plc — 0.25%
SG Americas Securities LLC — 0.07%
Learn More about top institutional investors of Corbus Pharmaceuticals stock.
Which major investors are selling Corbus Pharmaceuticals stock?: In the last quarter, CRBP stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Within the last year, company insiders that have sold Corbus Pharmaceuticals company stock include:
Cormorant Asset Management, Lp (Major Shareholder)
Yuval Cohen (CEO)
Learn More investors selling Corbus Pharmaceuticals stock.
Which major investors are buying Corbus Pharmaceuticals stock?: Within the last quarter, CRBP stock was acquired by institutional investors including:
abrdn plc
SG Americas Securities LLC